Evidence map›Paper›PMID 26557925›Full record

ArticleThoracic cancer2015

China national lung cancer screening guideline with low-dose computed tomography (2015 version).

Qing-Hua Zhou, Ya-Guang Fan, Hong Bu, Ying Wang, Ning Wu, Yun-Chao Huang, Guiqi Wang, Xin-Yun Wang, You-Lin Qiao

Open access · goldAbstract read
In one paragraph

Article in Thoracic cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 7 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 7 syntheses or guidelines pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2017
    Guideline
  5. Pooled it
  6. Guideline
  7. [Systematic Review of the Methodology Quality in Lung Cancer Screening Guidelines].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2016
    Pooled it
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Comparison of clinical diagnostic value of spiral CT with different dose in patients with early-stage peripheral lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Qing-Hua ZhouLung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University Chengdu, China ; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital Tianjin, China.
Ya-Guang FanTianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital Tianjin, China.
Hong BuLung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University Chengdu, China ; Department of Pathology, West China Hospital, Sichuan University Chengdu, China.
Ying WangDepartment of Radiology, Tianjin Medical University General Hospital Tianjin, China.
Ning WuDepartment of Diagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing, China.
Yun-Chao HuangDepartment of Thoracic Cardiovascular Surgery, the Third Affiliated Hospital of Kunming Medical College (Yunnan Tumor Hospital) Kunming, China.
Guiqi WangDepartment of Endoscopy, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing, China.
Xin-Yun WangDepartment of Pathology, Tianjin Medical University General Hospital Tianjin, China.
You-Lin QiaoDepartment of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNTianjin Medical University General Hospital · CNSecond Affiliated Hospital of Kunming Medical College · CNSichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLung cancer is the leading cause of cancer-related death in China. Results from a randomized controlled trial using annual low-dose computed tomography (LDCT) in specific high-risk groups demonstrated a 20% reduction in lung cancer mortality.

methodsA China national lung cancer screening guideline was developed by lung cancer early detection and treatment expert group appointed by the National Health and Family Planning Commission, based on results of the National Lung Screening Trial, systematic review of evidence related to LDCT screening, and protocol of lung cancer screening program conducted in rural China.

resultsAnnual lung cancer screening with LDCT is recommended for high risk individuals aged 50-74 years who have at least a 20 pack-year smoking history and who currently smoke or have quit within the past five years. Individualized decision making should be conducted before LDCT screening. LDCT screening also represents an opportunity to educate patients as to the health risks of smoking; thus, education should be integrated into the screening process in order to assist smoking cessation.

conclusionsA lung cancer screening guideline is provided for the high-risk population in China.

Indexed as

Chinalow-dose computed tomographylung cancer screening guideline

Identifiers

PMID26557925
PMCPMC4632939
OpenAlexW1677365952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.